Thomas J. Schaefer - Jan 3, 2023 Form 3 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Financial Officer
Signature
Thomas Schaefer, by Attorney-in-fact, Solaeta Chan
Stock symbol
RKDA
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
3
Date filed
1/5/2023, 07:47 PM
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RKDA Common Stock 2.1K Jan 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 8K $3.67 Direct F1
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 4K $3.05 Direct F2
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 20K $2.09 Direct F3
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 23K $1.27 Direct F4
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 31K $1.27 Direct F5
holding RKDA Stock Option (Right to Buy) Jan 3, 2023 Common Stock 23K $0.94 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 7/27/2020 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F2 The options were granted on 1/21/2021 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F3 The options will vest monthly in equal installments over a period of four years from the date of the grant, 10/1/2021, subject to the Participant's continued service.
F4 The options will vest annually in equal installments over a period of two years from the date of the grant, 4/11/2022, subject to the Participant's continued service.
F5 The options were granted on 4/11/2022 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F6 The options will vest annually in equal installments over a period of three years from the date of the grant, 8/16/2022, subject to the Participant's continued service.